Introduction
============

In most mammalian cells, the ER ([@bib75]; [@bib63]; [@bib10]) and Golgi complex ([@bib56]) are believed to represent the major mobilizable intracellular Ca^2^+ stores ([@bib69]). Uptake of Ca^2^+ into these stores is mediated largely by sarco(endo)plasmic reticulum Ca^2^+--ATPases (SERCAs)[\*](#fn1){ref-type="fn"} ([@bib46]) and helps to maintain resting cytosolic Ca^2^+ concentrations (\[Ca^2^+\]~c~) at levels (∼10^−7^ M) some four orders of magnitude lower than in the extracellular space (∼10^−3^ M). Release of Ca^2^+ from the ER and Golgi complex is provoked by hormones and other agonists which generate inositol 1,4,5 trisphosphate (IP~3~) ([@bib7]) to open intracellular receptors ([@bib43]). In certain cell types, such as skeletal muscle, these stores are also accessed by "Ca^2^+-induced Ca^2^+ release", via receptors for the insecticide, ryanodine ([@bib39]; [@bib78]).

Secretory vesicles of both the dense core ([@bib27]; [@bib31]) and small synaptic types ([@bib4]) possess a substantial proportion of the total Ca^2^+ in cells specialized for peptide secretion. However, despite many studies, the role of secretory vesicles as Ca^2^+ buffers or stores remains controversial ([@bib59]; [@bib69]; [@bib85]).

Mobilization of dense core vesicle Ca^2^+ by IP~3~ was originally suggested as a possibility in chromaffin cells ([@bib86]). Later data suggested that IP~3~ receptors may be present on the vesicle membrane in insulin-secreting cells ([@bib9]), though subsequent experiments showed the antibody used cross-reacted with insulin ([@bib61]). IP~3~, as well as the receptor (RyR) agonist cyclic ADP ribose (cADPr) ([@bib19]) have been reported to release Ca^2^+ from individual acinar cell zymogen granules ([@bib21]), although contamination of these preparations (e.g., with ER or Golgi apparatus--derived vesicles) is a potential problem ([@bib87]). Finally, evidence for the direct participation of secretory granules in the control of cytoplasmic Ca^2^+ concentration was recently provided in intact goblet cells ([@bib50]).

At present, the molecular mechanisms responsible for Ca^2^+ uptake into secretory vesicles are also a matter of controversy. At high Ca^2^+ concentrations (\>50 μM), uptake into dense core vesicles in permeabilized hypophysial cells ([@bib82]; [@bib80]) and into isolated chromaffin cell granules ([@bib38]) can occur via Na^+^/Ca^2^+ exchange, while synaptic vesicles also accumulate Ca^2^+ via a Ca^2^+-H^+^ antiport system ([@bib23]). However, the pump/exchange mechanisms active at physiological \[Ca^2^+\]~c~ are uncertain.

To examine the pathways by which Ca^2^+ crosses the limiting membrane of the dense core secretory vesicle of living islet β-cells, we have developed a new approach to monitor the free Ca^2^+ concentration within the secretory vesicle matrix (\[Ca^2^+\]~SV~) using recombinant targeted aequorin ([@bib64]). Cloned from the jellyfish *Aequorea victoria* ([@bib32]), aequorin is a calcium-sensitive bioluminescent protein ([@bib15]), previously used to measure free Ca^2^+ concentrations in a variety of subcellular organelles ([@bib69]). Importantly, aequorin activity is less severely inhibited at low pH values (\<6.5; [@bib8]) than Ca^2^+ probes based on green fluorescent protein (GFP) ([@bib44]; [@bib6]; [@bib18]). If appropriately targeted, this probe should allow Ca^2^+ concentrations to be measured in the acidic environment of the secretory granule interior ([@bib52]).

Vesicle-associated membrane protein (VAMP)2/synaptobrevin ([@bib76]) is a vesicle-specific SNARE with a single transmembrane-spanning region. Expression of chimaeric cDNA encoding a fusion protein between VAMP2 and aequorin (VAMP.Aq) has therefore allowed the intravesicular-free Ca^2^+ concentration to be monitored dynamically in live MIN6 β-cells. With this approach, we show that Ca^2^+ is actively pumped into dense core vesicles when \[Ca^2^+\]~c~ increases, and may be released via RyR, but not IP~3~, receptors. This release may be important at sites of high intracellular Ca^2^+, including sites of exocytosis at the plasma membrane.

Results
=======

Subcellular targeting of recombinant VAMP.aequorin
--------------------------------------------------

Chimeric cDNA encoding hemagglutinin (HA)1-tagged aequorin, fused to VAMP2 ([@bib76]), was generated as shown in [Fig. 1](#fig1){ref-type="fig"} A.

![**Localization of VAMP.Aq.** (A) Schematic map of VAMP.Aq. VAMP2 and aequorin cDNAs were fused via an HA1 epitope tag linker (Materials and methods) in order to localize mutated aequorin to the secretory vesicle lumen. (B) Confocal immunolocalization of VAMP.Aq. MIN6 cells were transfected with VAMP.Aq and stained with (a) mouse anti-HA1 monoclonal antibody (1:200) and (b) guinea pig antiinsulin antibody (1:150). (c) Extent of colocalization. (C) Immunoelectron microscopic localization of insulin (15-nm gold) or VAMP.Aq (anti-HA tag, 10-nm gold). Morphometric analysis of separate sections from 10 singly labeled cells revealed the following distribution of anti-HA gold particles: dense core vesicles, 36; ER, 2; Golgi apparatus, 0; plasma membrane, 16; endosomes, 19.](0103145f1){#fig1}

Immunocytochemical analysis of MIN6 cells transfected with VAMP.Aq cDNA revealed close overlap with insulin staining ([Fig. 1](#fig1){ref-type="fig"} B). Explored at a higher resolution by immunoelectron microscopy ([Fig. 1](#fig1){ref-type="fig"} C), VAMP.Aq immunoreactivity was highly enriched in 61 of 148 (41.2%; *n* = 11 cells) vesicles colabeled for insulin ([Fig. 1](#fig1){ref-type="fig"} C). Analyzed by single labeling for VAMP.Aq, staining of the ER, Golgi apparatus, and small synaptic-like microvesicles ([@bib62]) was very low, while reactivity was also present on the plasma membrane and in endosomes (see the legend to [Fig. 1](#fig1){ref-type="fig"} and Discussion).

Reconstitution and calibration of secretory vesicle and ER-targeted aequorins
-----------------------------------------------------------------------------

Given the high total Ca^2^+ content of secretory vesicles ([@bib31]), we used the approach adopted previously to measure Ca^2^+ in the ER lumen ([@bib47]). Apoaequorin was reconstituted at a low free Ca^2^+ concentration ([@bib47]), achieved by depleting cells of Ca^2^+ (Materials and methods). Depletion of vesicle Ca^2^+ had no marked effect on glucose or K^+^-stimulated insulin secretion, or on vesicle motility ([@bib58]; [@bib83]; unpublished data).

To determine the response of the expressed aequorins to Ca^2^+ in situ, permeabilized cells were incubated at buffered Ca^2^+ concentrations in the presence of ionomycin and monensin ([Fig. 2, C and E](#fig2){ref-type="fig"}). The sensitivity to Ca^2^+ (at pH 7.0) of the VAMP.Aq chimaera was similar to that reported previously for mutant (D^119^A) aequorin ([@bib47]). Intravesicular pH in intact cells was determined using a fusion construct between VAMP2 and a mutated, pH-sensitive GFP (pH.fluorin(e); Miesenbock et al., 1998), and gave a pH value of 6.3 ± 0.02 (*n* = 85 cells; [Fig. 2](#fig2){ref-type="fig"} A). Confirming that this low intravesicular pH was unlikely to significantly affect VAMP.Aq, near identical calibration data were obtained at pH 5.7 (unpublished data). Therefore, we used the constants obtained in vitro ([@bib47]) to calculate \[Ca^2^+\] from the fractional rate of aequorin consumption (F) according to: \[Ca^2^+\] = 1.44√10^(LOG\[F\]^−^3.4)^ ([@bib67]).

![**Measurement of intravesicular pH (A) and Ca** ^2^+ **with cytosolic aequorin (B), VAMP.Aq (C and D), and ER.Aq (E and F).** (A) Confocal images were acquired from cells transfected with pH.fluorin(e) ([@bib42]), maintained initially in KRB, pH 7.4, before digitonin-permeabilization and exchange into IB at the specified pH values, and buffered with morpholinosulphonic acid, Hepes, or TRIS (10 mM), plus 10 μM ionomycin, 10 μM monensin, and 1 μM FCCP. Normalized fluorescence ratios before permeabilization were in the range of 0.16--0.18 (arrow); data were fitted using the Graph Pad Prism^TM^. (C and E) After Ca^2^+ depletion and aequorin reconstitution, transfected cells were permeabilized with digitonin and perifused in the presence of ionomycin, monensin, and CPA (10 μM each) with N-(2-hydroxyethyl)ethylene diamine triacetate (HEDTA)-buffered Ca^2^+ solutions at 0.5 mM calculated free Mg^2+^. Cells expressing either (B) cytosolic aequorin, (D) VAMP.Aq, or (F) ER.Aq were perifused with KRB, supplemented with 1 mM EGTA (KRB/EGTA) and, where indicated, EGTA was replaced with 1.5 mM CaCl~2~. Cells were finally lysed in Ca^2^+-rich hypotonic medium (10 mM CaCl~2~, 0.1 mM digitonin) for calibration (see Materials and methods and Results). The background count rate (∼1,200 cps; D and F) was identical during perifusion of untransfected cells and is due to autooxidation of coelenterazine *n*.](0103145f2){#fig2}

Dynamic measurement of secretory vesicle and ER Ca^2^ **+** concentrations
--------------------------------------------------------------------------

To monitor uptake of Ca^2^+ into vesicles in living cells, we provoked rapid Ca^2^+ influx into cells through store-operated channels ([@bib54]). During reintroduction of CaCl~2~ to cells previously perifused in EGTA, \[Ca^2^+\]~c~ approached 500 nM, then fell back to 150--200 nM ([Fig. 2](#fig2){ref-type="fig"} B). By contrast, steady state free \[Ca^2^+\] in the secretory vesicle matrix was 30--90 μM (51; 7.5 μM; *n* = 5 separate cultures; [Fig. 2](#fig2){ref-type="fig"} D), whereas free \[Ca^2^+\] in the ER lumen was fivefold higher (249; 12.9 μM; *n* = 3 preparations; [Fig. 2](#fig2){ref-type="fig"} F).

Pathways of Ca^2^ **+** uptake into dense core secretory vesicles
-----------------------------------------------------------------

Both the rate and extent of the \[Ca^2^+\] increases in the secretory vesicles and the ER were strongly dependent on the presence of added ATP in permeabilized cells ([Fig. 3, A and D](#fig3){ref-type="fig"}). The increase in \[Ca^2^+\]~SV~ upon reintroduction of Ca^2^+ ions was completely inhibited by the P-type Ca^2^+ pump inhibitor, orthovanadatate, at \>100 μM ([Fig. 3](#fig3){ref-type="fig"} B), but was insensitive to 10 μM orthovanadatate, a concentration which strongly inhibits the plasma membrane Ca^2^+-ATPase ([@bib12]). Preincubation with the specific SERCA inhibitor, thapsigargin ([@bib79]), and perifusion with cyclopiazonic acid (CPA) ([@bib41]) had no effect on the changes in \[Ca^2^+\]~SV~ ([Fig. 3](#fig3){ref-type="fig"} C and [Table I](#tbl1){ref-type="table"}), but markedly (\>85%) inhibited ER \[Ca^2^+\] increases ([Fig. 3](#fig3){ref-type="fig"} E).

![**Ca** ^2^+ **uptake into secretory vesicles (A--C) or ER (D and E).** After Ca^2^+ depletion and aequorin reconstitution, cells were permeabilized with 20 μM digitonin in IB; (A and D; see Materials and methods). Cells were perifused initially at \<10^−9^ M free \[Ca^2^+\] (buffered with 0.2 mM EGTA, 1 mM HEDTA; free \[Mg^2+^\] = 0.5 mM) and then at 400 nM free \[Ca^2^+\], as indicated. Where present (closed symbols) ATP was 1 mM. Note that accumulation of Ca^2^+ at zero ATP is likely to be due to synthesis of small amounts of ATP by mitochondria. (B) Dose--response for the inhibition of vesicular \[Ca^2^+\] increases by orthovanadate. Cells expressing VAMP.Aq were permeabilized and perifused at 400 nM Ca^2^+ in the presence of 1 mM ATP, plus the indicated concentrations of NaVO~4~. The initial rates of \[Ca^2^+\]~SV~ increase upon the stepped increase in perifusate-free \[Ca^2^+\] from \<1 to 400 nM were calculated by fitting time course data to a simple first order rate equation by nonlinear regression analysis (Microsoft Excel^TM^). (C and E) After Ca^2^+ depletion and aequorin reconstitution, Ca^2^+ uptake into intact cells was initiated by replacing KRB containing 1 mM EGTA with EGTA-free KRB at 1.5 mM CaCl~2~, as indicated. Closed symbols, cells were incubated with thapsigargin (TG; 1 μM) during the final 10 min of reconstitution, and the perifusion medium was supplemented with CPA (10 μM). Data are representative of three separate experiments in each case.](0103145f3){#fig3}

###### 

**Kinetic paramers for Ca** ^2^+ **uptake into the ER versus secretory vesicles**

     Steady state \[Ca^2^+\] ± SE   *t* ~1/2~ ± SE   K~initial~   *n*
  -- ------------------------------ ---------------- ------------ -----
     μM                             s                μM/s         

Kinetic values were calculated by fitting time course data ([Fig. 3](#fig3){ref-type="fig"}) to a simple first order exponential curve by nonlinear least squares regression (Microsoft Excel™).

*P* \< 1%.

Arguing against vesicular Ca^2^+ uptake via Ca^2^+/H^+^ exchange, monensin, an Na^+^/H^+^ exchanger, had no effect on \[Ca^2^+\]~SV~ increases in permeabilized cells ([Fig. 4](#fig4){ref-type="fig"} A). Similarly, ionomycin (a Ca^2^+/H^+^ exchanger) decreased \[Ca^2^+\]~SV~ marginally (∼20%; [Fig. 4](#fig4){ref-type="fig"} B), which is consistent with the inability of this ionophore to bind to and transport Ca^2^+ against a prevailing H^+^ gradient, but caused a rapid and complete decline in \[Ca^2^+\]~SV~ in the additional presence of monensin ([Fig. 4](#fig4){ref-type="fig"} B). Neither the vacuolar H^+^-ATPase inhibitor, bafilomycin ([Fig. 4, C and D](#fig4){ref-type="fig"}), nor the protonophore carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), had any effect on vesicular Ca^2^+ uptake ([Fig. 4](#fig4){ref-type="fig"} E).

![**Effects of collapse of H** ^+^ **and Na** ^+^ **gradients on vesicular** Ca^2^+ **accumulation in permeabilized cells.** Cells were Ca^2^+ depleted and aequorin reconstituted with coelenterazine *n* before digitonin permeabilization. Cells were perifused in IB (Materials and methods) and free \[Ca^2^+\] was increased from \<1 to 400 nM as indicated, either in the absence (A, C, E, and F, open symbols) or in the presence of the additions (closed symbols) as follows: A, 10 μM monensin; B, when indicated, 10 μM ionomycin (triangles), or ionomycin plus 10 μM monensin (circles); C, 300 nM bafilomycin; E, 1 μM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP); F, 140 mM NaCl. Trace (D) shows the effect of bafilomycin on vesicular acridine orange fluorescence in 10 individual cells imaged simultaneously (Materials and methods). Data are representative of at least three separate experiments or are the means ± SEM of three (B).](0103145f4){#fig4}

\[Ca^2^+\]~SV~ increases were also completely unaffected by raising \[Na^+^\] from 0, 2, or 140 mM ([Fig. 4](#fig4){ref-type="fig"} F), and by simultaneous blockade of Na^+^/Ca^2^+ exchange and Ca^2^+/H^+^ exchange (zero Na^+^, 300 nM bafilomycin; unpublished data).

Effects of IP~3~ on \[Ca^2^ **+**\]~SV~ and \[Ca^2^ **+**\]~ER~
---------------------------------------------------------------

To achieve large changes in intracellular IP~3~ levels, we coexpressed the metabotropic glutamate receptor, mGluR5, with VAMP.Aq or ER.Aq. Stimulation of mGluR5-transfected cells with the specific agonist, (S)-3,5-dihydroxyphenylglycine (DHPG) ([@bib81]) caused a significant decrease in \[Ca^2^+\]~ER~ ([Fig. 5](#fig5){ref-type="fig"} E), but an increase in \[Ca^2^+\]~SV~ ([Fig. 5](#fig5){ref-type="fig"} A). DHPG had no significant effect on the distribution of vesicles (imaged after expression of VAMP.GFP/pHfluorin (r); [Fig. 5](#fig5){ref-type="fig"} D), indicating that enhanced exocytosis and exposure of the VAMP.Aq to the extracellular medium was unlikely to contribute to the observed increases in \[Ca^2^+\]~SV~ ([Fig. 5](#fig5){ref-type="fig"} A, and see Discussion).

![**Effect of IP~3~ on \[Ca^2^**+**\]~SV~ and \[Ca^2^**+**\]~ER~ in intact (A and E) and permeabilized (B, C, F, and G) cells.** MIN6 cells were cotransfected with (A) VAMP.Aq or (E) ER.Aq plus a plasmid bearing mGluR5 cDNA. After the depletion of intracellular Ca^2^+ stores and aequorin reconstitution, cells were perifused in KRB, which initially contained 1 mM EGTA. Where indicated, EGTA was replaced with 1.5 mM CaCl~2~. After the achievement of steady state \[Ca^2^+\], cells were challenged with the mGluR5 receptor agonist DHPG (30 μM) as indicated. Data are means of five independent experiments. (B, C, F, and G) Cells transfected with plasmids encoding VAMP.Aq (B and C) or ER.Aq (F and G) were Ca^2^+ depleted and aequorin was reconstituted before permeabilization and perifusion in IB buffer which initially contained 0.1 mM EGTA (free \[Ca^2^+\] \<1 nM). HEDTA and CaCl~2~ were added to give a calculated free \[Ca^2^+\] of 200 nM, as indicated. After the achievement of steady state \[Ca^2^+\]~SV~ or \[Ca^2^+\]~ER~, IP~3~ (5 μM) was introduced (filled symbols) as shown (B and F). Mean steady state \[Ca^2^+\]~SV~ and \[Ca^2^+\]~ER~ in three separate experiments in the presence or absence of IP~3~ are shown in C and G, respectively. Double asterisk indicates *P* \< 1% for the effect of IP~3~ on \[Ca^2^+\]~ER~. D shows cells cotransfected with VAMP.GFP (pH.fluorin(r); Miesenbock et al., 1998) and mGluR5 cDNAs and depleted of Ca^2^+, as in A. Localization of vesicles (a) after 1 h of Ca^2^+- depletion, (b) 120 s after readdition of CaCl~2~, and (c) 60 s after DHPG addition.](0103145f5){#fig5}

Similarly, in permeabilized cells, IP~3~ had no effect on \[Ca^2^+\]~SV~ ([Fig. 5, B and C](#fig5){ref-type="fig"}), while causing a large decrease in \[Ca^2^+\]~ER~ ([Fig. 5, F and G](#fig5){ref-type="fig"}).

RyR activation decreases \[Ca^2^ **+**\]~SV~ and \[Ca^2^ **+**\]~ER~
--------------------------------------------------------------------

The RyR agonists caffeine or 4-chloro-3-ethylphenol (4-CEP) ([@bib88]) provoked rapid decreases in \[Ca^2^+\]~SV~ and \[Ca^2^+\]~ER~ ([Fig. 6, A and C](#fig6){ref-type="fig"}) in intact cells. Similarly, cADPr ([@bib19]) caused clear decreases in both parameters in permeabilized cells ([Fig. 6, B and D](#fig6){ref-type="fig"}), and the effects of cADPr were strongly potentiated by palmitoyl CoA ([Fig. 6, B and D](#fig6){ref-type="fig"}), a coagonist of RyRs ([@bib14]).

![**Effect of RyR agonists on secretory vesicle and ER Ca^2^**+ **concentrations.** Cells were transfected (A and C) or infected with adenoviruses (B and D) encoding either VAMP.Aq (A and B) or ER.Aq (C and D), then perifused in KRB containing 1 mM EGTA (A and C) or digitonin permeabilized and perifused with IB which initially contained 0.1 mM EGTA (B and D). Replacement of EGTA with 1.5 mM CaCl~2~ (intact cells, A and C), or an increase in perifusate-free \[Ca^2^+\] to 200 nM (permeabilized cells, B and D), as indicated. Other additions were: caffeine, 10 mM; 4-CEP, 500 μM; cADPr, 5 μM; palmitoyl CoA, 50 μM.](0103145f6){#fig6}

4-CEP mobilizes Ca^2^ **+** from an acidic, CPA-insensitive store in fura-2--loaded MIN6 cells
----------------------------------------------------------------------------------------------

The above results suggested that activation of RyR on vesicles should cause an increase in cytoplasmic \[Ca^2^+\]~c~, even after the depletion of the ER Ca^2^+ pool. Added to fura-2--loaded MIN6 cells, 4-CEP caused a substantial increase in \[Ca^2^+\]~c~ in the absence of external Ca^2^+ ([Fig. 7](#fig7){ref-type="fig"} A). This \[Ca^2^+\]~c~ increase was partly retained after depletion of SERCA-dependent stores, giving a peak \[Ca^2^+\]~c~ increase of 30--40% of that in control cells ([Fig. 7](#fig7){ref-type="fig"} B versus A). The \[Ca^2^+\]~c~ increase elicited by 4-CEP was also partially retained after treatment of cells with ionomycin ([Fig. 7](#fig7){ref-type="fig"} C), but completely abolished after treatment with ionomycin plus monensin, to deplete acidic Ca^2^+ stores ([Fig. 7](#fig7){ref-type="fig"} D). Demonstrating that the effects of 4-CEP on \[Ca^2^+\]~SV~ were likely mediated by RyR, immunoreactivity to these channels was revealed on vesicle membranes by direct immunoelectron microscopy ([Fig. 7](#fig7){ref-type="fig"} E).

![**Effect of caffeine and 4-CEP on cytosolic \[Ca^2^**+**\].** (A--D) Cells were loaded with fura-2 and imaged as described (Materials and methods). Where indicated (B--D), cells were preincubated with 1 μM thapsigargin in Ca^2^+-free KRB (supplemented with 1 mM EGTA for 10 min) and then subsequently perifused in Ca^2^+-free medium, initially in the absence of thapsigargin or other additions. Trace (A) shows the effect of 500 μM 4-CEP, added as indicated, on \[Ca^2^+\]~c~ in cells untreated with thapsigargin, and (B) the effect of the drug on cells treated with thapsigargin and subsequently perifused in the presence of 10 μM CPA. Note the abolition of the response to carbachol, which caused a large increase in \[Ca^2^+\]~c~ in untreated cells (unpublished data). In C, CPA and ionomycin (10 μM each) were added as indicated. Panel D was as C, but with the further addition of monensin (mon, 10 μM) to the perifusate. Data are the means (± SEM) on observations on a total of (A) 58, (B) 35, (C) 28, and (D) 40 single cells, imaged in 3--5 separate experiments. (E) Immunoelectron microscopic localization of RyR (arrows) on dense core vesicles.](0103145f7){#fig7}

Effects of nutrient secretagogues on \[Ca^2^ **+**\]~ER~ and \[Ca^2^ **+**\]~SV~
--------------------------------------------------------------------------------

Exposure of islet β- or MIN6 cells to glucose or other nutrients causes an increase in intracellular-free \[ATP\] ([@bib37]) closure of ATP-sensitive K^+^ (K~ATP~) channels ([@bib11]) and Ca^2^+ entry via voltage-sensitive (L-type) Ca^2^+ channels ([@bib70]).

High (20 mM) glucose, or a combination of nutrient secretagogues ([@bib5]), caused a large increase in steady state \[Ca^2^+\] both in the ER and in vesicles ([Fig. 8, A and C](#fig8){ref-type="fig"}), with no significant change in vesicular distribution ([Fig. 8](#fig8){ref-type="fig"} B), which is consistent with the increases in \[Ca^2^+\]~c~ seen under these conditions ([@bib24]).

![**Effect of nutrient secretagogues on steady state \[Ca^2^**+**\] in secretory vesicles and the ER.** Ca^2^+ depletion, and aequorin reconstitution, were carried out as described in [Fig. 3](#fig3){ref-type="fig"} before exposure of cells expressing VAMP.Aq (A) or ER.Aq (C) to the concentrations of nutrients shown for 2 min in complete KRB medium containing 1.5 mM CaCl~2~. Mixed nutrients, 20 mM glucose, 10 mM glutamine, 10 mM leucine. In all cases, cells were preperifused for 5 min and maintained in the presence of 1 mM 3-isobutyl-1- methylxanthine (IBMX). Asterisk indicates *P* \< 5%; double asterisk indicates *P* \< 1% for the effect of 20 mM glucose or mixed nutrients, respectively. In B, cells expressing VAMP.GFP (pH.fluorin(e)) were Ca^2^+ depleted as in A, before (a and c) or after (b and d) reintroduction of CaCl~2~ in the presence of 3 mM (a and b) or 30 mM (c and d) glucose. Bar, 5 μm.](0103145f8){#fig8}

Discussion
==========

Aequorin as a reporter of secretory vesicle--free Ca^2^ **+** concentration
---------------------------------------------------------------------------

We show here that aequorin can be targeted to the lumen of dense core secretory vesicles in living cells, with no incorporation into the ER, Golgi, or trans-Golgi network using the cell\'s own protein-sorting machinery ([Fig. 1](#fig1){ref-type="fig"}). However, a proportion of VAMP.Aq was also present on the plasma membrane and endosomes ([Fig. 1](#fig1){ref-type="fig"} C). Since our recordings were made at either high (1.5 mM, intact cells) or low (400 nM, permeabilized cells) external Ca^2^+ concentrations, the plasma membrane--located photoprotein should be either rapidly exhausted, or inactive, respectively. In any case, it would appear that plasma membrane--targeted aequorin is not reconstituted, since we would have expected to see a "spike" of luminescence upon readdition of high Ca^2^+ concentrations to intact cells (e.g., [Fig. 3](#fig3){ref-type="fig"} C). None was seen, suggesting that the mistargeted protein may be inactivated by unknown mechanisms during recycling between the plasma membrane and endosomes.

Similarly, endosomal aequorin is likely to be inactive under our conditions, since (a) the total endosomal Ca^2^+ content is low in neuroendocrine cells ([@bib55]) and (b) free \[Ca^2^+\] is particularly low (∼3.0 μM) in acidic endosomes ([@bib22]); active VAMP.Aq was located exclusively in an acidic compartment ([Fig. 4](#fig4){ref-type="fig"} B). Simulation of the contribution of endosomal VAMP.Aq reveals that our measurements may slightly underestimate \[Ca^2^+\]~SV~ (by \<10%; unpublished data).

Mutated aequorins respond well to Ca^2^+ concentrations over the range (30--90 μM) which pertains within the secretory vesicle, as well as the rest of the secretory pathway (200--300 μM) ([@bib48]; [@bib56]), without significant interference from the low pH environment. This feature of aequorin contrasts with GFP-based Ca^2^+ probes ([@bib44]; [@bib6]; [@bib18]), whose fluorescence is strongly reduced at acidic pHs ([@bib42]; [Fig. 2](#fig2){ref-type="fig"} E). Thus, aequorin may represent the most suitable molecularly targetable Ca^2^+ reporter presently available for the secretory vesicle interior.

Free Ca^2^ **+** concentration in the secretory vesicle lumen
-------------------------------------------------------------

Despite possessing a larger total Ca^2^+ content ([@bib3]; [@bib31]; [@bib51]), secretory vesicles displayed a significantly lower free \[Ca^2^+\] than the ER or Golgi apparatus. Our measured values for \[Ca^2^+\]~SV~ (∼50 μM) correspond fairly well to measurements using other techniques in isolated chromaffin granules ([@bib38]; 24 μM; null point titration), respiratory tract goblet cells (24 μM; calcium orange 5 N fluorescence; [@bib50]) and platelet α-granules (12 μM; null point titration; [@bib25]). Thus, free Ca^2^+ represents \<0.05% of the total vesicular calcium content of β-cell secretory vesicles (assuming a total Ca^2^+ concentration of 50--100 mM; [@bib31]). Secretory vesicles appear to have the highest Ca^2^+-buffering capacity of all subcellular organelles so far examined, with the percentage of free Ca^2^+ being much higher both in the cytosol (∼2%) and in the ER (∼10%; [@bib59]). Importantly, resting \[Ca^2^+\]~SV~ was well below the K~M~ for Ca^2^+ of proinsulin-processing enzymes ([@bib17]).

The identity of the Ca^2^+ binding proteins (or other molecules) responsible for chelating free Ca^2^+ in these vesicles is unknown. Chromogranins ([@bib86]), or the mammalian homologue of *Tetrahymena thermophila* granule lattice protein 1 (Grlp1) ([@bib13]), are each strong possibilities. In addition, Ca^2^+ chelation by small molecules, such as ATP ([@bib31]), may also be involved. Finally, it is likely that in islet β-cells the insulin crystal itself also participates in chelating vesicular Ca^2^+ ([@bib53]; see below).

Uptake of Ca^2^ **+** into secretory vesicles
---------------------------------------------

The dense core secretory vesicle pool of islet β-cells has previously been considered relatively inert ([@bib29]; [@bib60]). We provide evidence here that net uptake of Ca^2^+ into the dense core secretory vesicle population occurs during activated Ca^2^+ influx ([Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), and in response to a receptor agonist ([Fig. 5](#fig5){ref-type="fig"}) or to nutrients ([Fig. 8](#fig8){ref-type="fig"}). However, and as discussed below (see also [Fig. 9](#fig9){ref-type="fig"}), these measurements do not exclude the possibility that discrete vesicle pools may experience different \[Ca^2^+\]~SV~ changes.

![**Scheme: redistribution of organellar Ca^2^**+ **in secretory cells in response to G protein--coupled receptors (e.g., acetyl choline, AcCh) or glucose.** IP~3~ generated in response to AcCh releases Ca^2^+ from the endoplasmic reticulum and Golgi apparatus, leading to an increase in cytosolic \[Ca^2^+\] and uptake of Ca^2^+ into dense core secretory vesicles distant from the plasma membrane (deep vesicles). Vesicular Ca^2^+ uptake is catalyzed by an undefined Ca^2^+-ATPase, with properties similar to PMR1/ATP2C1 (see Discussion). Increases in blood glucose lead to (1) the uptake of the sugar via glucose transporters, (2) enhanced ATP synthesis and closure of ATP-sensitive K^+^ channels, and (3) Ca^2^+ influx through L-type Ca^2^+ channels. The resultant increases in \[Ca^2^+\]~c~ are likely to promote net Ca^2^+ uptake (reflecting the balance of uptake versus release) into vesicles distant from the cell surface (deep vesicles). For those vesicles (\<0.5% of total; [@bib65]) located close to the plasma membrane and primed for exocytosis (primed vesicles), larger local \[Ca^2^+\]~c~ increases (e.g., at the mouth of activated plasma membrane Ca^2^+ channels; [@bib49]) may activate vesicular RyRs and provoke net Ca^2^+ release.](0103145f9){#fig9}

We considered the possibility that the increases in \[Ca^2^+\]~SV~ observed upon challenge of cells with agonists ([Fig. 5](#fig5){ref-type="fig"}) or nutrients ([Fig. 8](#fig8){ref-type="fig"}) may be due in part to the activation of exocytosis, and thus the exposure of aequorin within the vesicle matrix to the extracellular Ca^2^+ concentrations (1.5 mM). However, this phenomenon is likely to contribute negligibly to the observed signals, since only a tiny fraction of the total vesicle population (the "primed" pool) in β-cells (5--20/13,000 per min; [@bib65]) undergoes fusion, even during the maximal stimulation of exocytosis. Consistent with this, we could detect no significant net movement of VAMP.GFP fluorescence to the plasma membrane after stimulation with DHPG ([Fig. 5](#fig5){ref-type="fig"} D) or nutrients ([Fig. 8](#fig8){ref-type="fig"} B).

Changes in intravesicular Ca^2^+ concentration detected with vesicle-targeted aequorin seem likely to result largely from the flux of Ca^2^+ ions across the vesicle membrane. However, two caveats are important: (a) Ca^2^+ release from/association with binding sites (or a "polyanionic matrix") ([@bib50]) within the vesicle may also occur, especially if the intravesicular concentrations of other ions (e.g., K^+^) change; (b) the number of Ca^2^+ ions that are transported is unknown, since this depends on the binding to intraorganellar sites. As discussed above, the present studies demonstrate that the ratio of free to bound Ca^2^+ within the secretory vesicles is much lower than that in the ER or Golgi lumen. This would appear at first to suggest that changes in intravesicular Ca^2^+ concentration must involve the flux of a very large number of Ca^2^+ ions. However, an alternative possibility is that there are two (or more) pools of bound Ca^2^+ in the secretory vesicle, one (the larger) comprising Ca^2^+ which is tightly bound (perhaps to a structural component such as the insulin crystal) and the other a more loosely bound and readily exchangeable pool. Depletion of this latter, "labile" pool, may thus lead to a substantial decrease in the free vesicular \[Ca^2^+\], while involving the release into the cytosol of relatively few Ca^2^+ ions.

The present data suggest that Ca^2^+ accumulation into vesicles is catalyzed at physiological \[Ca^2^+\]~c~ chiefly by a P-type Ca^2^+-ATPase. Previous studies have indicated that transport of Ca^2^+ into the Golgi apparatus is mediated partly by a SERCA pump, and partly by another, unidentified thapsigargin-insensitive system ([@bib56]). This second ATP-dependent Ca^2^+ uptake system may be closely related to ATP2C1 ([@bib30]), the mammalian homologue of the yeast Golgi Ca^2^+ transport ATPase, PMR1 ([@bib74]). Supporting this view, mRNA-encoding ATP2C1 is abundant in MIN6 cells, and polyclonal antibodies raised to ATP2C1 reveal a punctate pattern of intracellular staining (unpublished data). Intriguingly, although patients defective in the *ATP2C1* gene develop skin lesions ("Hailey-Hailey" disease; [@bib30]), it is unclear whether these individuals also tend to suffer from neuroendocrine or other disorders (e.g., diabetes mellitus).

Secretory vesicles are an IP~3~-insensitive, but caffeine/cADPr-sensitive Ca^2^ **+** store
-------------------------------------------------------------------------------------------

The present results suggest that IP~3~ is unlikely to stimulate the release of Ca^2^+ from dense core secretory vesicles directly ([Fig. 5](#fig5){ref-type="fig"}).

By contrast, we now show ([Figs. 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}) that functional RyR channels are present on the dense core vesicle membrane of MIN6 cells. Type II RyR mRNA is present in *ob/ob* mouse islets, mouse β-TC3 cells ([@bib34]), and in rat islets ([@bib28]). RyR II protein has been detected in INS1 β-cells ([@bib20]), and ryanodine binding sites revealed in human islets ([@bib28]), mouse islets and MIN6 cells ([@bib84]). Evidence for functional RyRs on the ER INS-1 β-cells ([@bib40]) has also recently been provided. The present data indicate that dense core vesicles may represent a large fraction (∼30%) of the total RyR--accessible Ca^2^+ pool in MIN6 β-cells ([Fig. 7](#fig7){ref-type="fig"} B). However, the proportion of the total vesicular Ca^2^+ pool which is mobilizable via RyR is small. Thus, the \[Ca^2^+\]~c~ increases observed when the total acidic Ca^2^+ pool was emptied with CPA, ionomycin, and monensin ([Fig. 7](#fig7){ref-type="fig"} D) were much larger than those apparent when cells were treated with 4-CEP after CPA and ionomycin ([Fig. 7](#fig7){ref-type="fig"} C).

Role of cADPr in β-cells
------------------------

In the present studies, cADPr caused an apparent release of Ca^2^+ from both the ER and from the secretory vesicles in permeabilized MIN6 β-cells. Moreover, we have recently observed ([@bib84]) that photolysis of caged cADPr increases \[Ca^2^+\]~c~ in MIN6 cells. These findings were surprising in light of earlier results using *ob/ob* mouse islets ([@bib33]) or INS-1 β-cells ([@bib68]), where cADPr was ineffective in permeabilized cells. However, it should be noted that the present studies may provide greater sensitivity to small Ca^2^+ fluxes by measuring changes in \[Ca^2^+\] inside the secretory vesicle or ER.

Could changes in intracellular cADPr concentration play a role in the regulation of insulin secretion as proposed by [@bib77]? Supporting this view, mice homozygous for inactivation of the *CD38* (ADPribose cyclase) gene display impaired glucose tolerance ([@bib35]). However, no change in the islet cADPr content was observed by others in response to acutely elevated glucose concentrations in vitro ([@bib72]), suggesting further studies are necessary.

Conclusions
-----------

Dense core secretory vesicles rapidly take up Ca^2^+ ions via an ATP-dependent non-SERCA Ca^2^+ pump (see Scheme, [Fig. 9](#fig9){ref-type="fig"}). Ca^2^+ accumulated into vesicles may later be released via RyRs once these vesicles reach a high local Ca^2^+ concentration beneath the plasma membrane ([@bib49]) or elsewhere in the cell. This release may further contribute to the high local \[Ca^2^+\]~c~ in the vicinity of the submembrane vesicles ([@bib18]), and may be important to trigger exocytosis ([@bib71]).

Materials and methods
=====================

Materials
---------

Cell culture reagents were obtained from GIBCO BRL or Sigma-Aldrich and molecular biologicals from Roche Diagnostics. Fura-2 and cADPr were from Sigma-Aldrich and IP~3~ was from Molecular Probes.

Construction of VAMP.Aq cDNA
----------------------------

VAMP2 cDNA was amplified by PCR using specific primers (forward: 5′-[AAG CTT]{.ul} ACC ATG TCG GCT ACC GCT GCC ACC-3′; reverse: 5′-[AAG CTT]{.ul} AGT GCT GAA GTA AAC GAT GAT-3′, HindIII sites are underlined). This fragment was then inserted upstream of the HindIII-EcoRI fragment encoding HA1-tagged D^119^-A aequorin ([@bib36]) in plasmid pBS+. Chimeric VAMP.Aq cDNA was shuttled as a NotI-XhoI fragment into pcDNAI (Invitrogen; [Fig. 1](#fig1){ref-type="fig"} A).

Construction of adenoviral VAMP.Aq and ER.Aq
--------------------------------------------

ER.Aq ([@bib47]) and VAMP.Aq cDNAs were transferred into plasmid pShuttleCMV ([@bib26]) as Kpn1-Xho1 and Xba1-HindIII fragments, respectively. The resultant constructs were recombined with vector pAdEasy-1, and viral particles were generated as described ([@bib1]).

Cell culture, transient transfection, and adenoviral infection
--------------------------------------------------------------

MIN6 β-cells ([@bib45]; passages \#20 and \#30) were cultured in DME, with additions as given previously ([@bib1]). Cells cultured on 13 mm poly-[l]{.smallcaps}-lysine--coated coverslips were transfected with VAMP.Aq or ER.Aq plasmid DNA (1 μg) using Lipofectamine (Promega) in Optimem I serum-free medium (GIBCO BRL), or infected with adenoviruses as described ([@bib1]). The total quantity of reconstituted aequorin was higher in cells transfected with ER.Aq than VAMP.Aq cDNAs due to the inclusion in the former of intronic regulatory elements. Thus, typical integrated counts/culture ([Fig. 2](#fig2){ref-type="fig"}) after the expression of VAMP.Aq were 3 × 10^5^ and 1.5 × 10^6^ for conventional and adenoviral expression, respectively, and 2 × 10^6^ and 2 × 10^7^ for ER.Aq.

\[Ca^2^ **+**\] measurement with expressed aequorins
----------------------------------------------------

Cells were Ca^2^+ depleted by incubation with ionomycin (10 μM), the SERCA inhibitor CPA (10 μM; [@bib41]; [@bib56]), and monensin (10 μM) in modified Krebs-Ringer bicarbonate buffer (KRB; 140 mM NaCl, 3.5 mM KCl, 0.5 mM NaH~2~PO~4~, 0.5 mM MgSO~4~, 3 mM glucose, 10 mM Hepes, 2 mM NaHCO~3~, pH 7.4) supplemented with 1 mM EGTA for 5 min at 4°C. Aequorin was reconstituted in 0.1 mM EGTA, 5 μM coelenterazine (cytosolic aequorin) or coelenterazine *n* ([@bib73]; VAMP.Aq, ER.Aq) for 1--2 h at 4°C.

Intact cells were perifused (2 mL/min^−1^) with KRB plus additions as stated (37°C) close to a photomultiplier tube (ThornEMI), and emitted light was collected (one data point) with a photon-counting board (ThornEMI; [@bib15]). Where indicated, cells were permeabilized with digitonin (20 μM, 1 min at 22°C) and subsequently perifused in intracellular buffer (IB) (140 mM KCl, 10 mM NaCl, 1 mM KH~2~PO~4~, 5.5 mM glucose, 2 mM MgSO~4~, 1 mM ATP, 2 mM Na^+^ succinate, 20 mM Hepes, pH 7.05) at 37°C.

\[Ca^2^ **+**\] imaging with fura-2
-----------------------------------

Cells were loaded with 5 μM fura-2-AM (Sigma-Aldrich) for 40 min (37°C) in KRB plus 0.05% Pluronic F-127 (BASF). \[Ca^2^+\]~c~ was monitored in single cells at 37°C as described ([@bib2]), using a Leica DM-IRBE inverted microscope (40× objective), and a Hamamatsu C4742-995 charge-coupled device camera driven by OpenLab (Improvision) software.

Imaging acridine orange fluorescence
------------------------------------

Permeabilized cells were loaded with 3 μM acridine orange ([@bib83]) before imaging (37°C) on a Leica DM-IRBE^TM^ inverted optics epiflurosecence microscope, at 493 ± 10 excitation, 530 nm emission (filters were from Chroma Techology).

Immunocytochemistry
-------------------

48 h after transfection or infection, cells were fixed in 3.7% (vol/vol) paraformaldehyde and probed with antibodies essentially as described ([@bib57]).

Immunoelectron microscopy
-------------------------

Gelatin-embedded, aldehyde-fixed cells were frozen in liquid nitrogen and ultrathin cryosections were obtained with a Reichert-Jung Ultracut E. Immunogold localization was performed as described ([@bib16]). Sections were immunostained either with rabbit anti-HA antibody (Sigma-Aldrich), or with a sheep anti-RyR antibody (Molecular Probes) followed by 10-nm protein A-gold. For double labeling, anti-HA--labeled sections were incubated with 1% glutaraldehyde in 0.1 M Na~2~PO~4~, pH 7.0, followed by incubation with a guinea pig antiinsulin antibody (Dako) and 15-nm protein A-gold. Sections were examined with a ZEISS EM 902 electron microscope. No labeling was detected in control sections (unpublished data).

Confocal imaging
----------------

Cells were imaged at 37°C on a Leica SP2 confocal spectrophotometer, (488 nm excitation) using a 100× oil immersion objective.

Other methods and statistics
----------------------------

Free \[Ca^2^+\] and \[Mg^2+^\] were calculated using "METLIG" ([@bib66]). Data are presented as the mean ± SEM for the number of observations given, and statistical significance calculated using Student\'s *t* test.
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